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Cerebral Perfusion 
in Aortic Arch Surgery
Antegrade, Retrograde, or Both?
S ince Cooley and DeBakey f irst replaced the transverse aortic arch over 50 years ago,1 outcomes from arch repair have improved. Despite these advances, challenges in preventing complications, such as neurologic injury, remain. 
Historically, various adjuncts have been developed to prevent neurologic injury, in-
cluding passive shunting and cardiopulmonary bypass, as described by Cooley and 
DeBakey in the 1960s.2 Griepp’s report3 on profound hypothermic circulatory arrest 
(PHCA) for arch repair led to a dramatic shift in the field by providing a simple ap-
proach to managing the aortic arch. Many adopted this approach for its simplicity 
and its ability to provide both cerebral and multiorgan protection. Crawford and 
associates reported respectable results when using PHCA,4 but drew attention to its 
limitation—its duration. They showed that increasing circulatory arrest times led to 
a greater risk of stroke and death.
 The following is a brief overview of current trends in adjunctive cerebral perfusion, 
which highlights antegrade and retrograde perfusion. It must be recognized, however, 
that cerebral perfusion is only one of many aspects to be considered in the prevention 
of neurologic injury; therefore, determining the superiority of one approach to perfu-
sion over another is difficult.
General Information
On average, the brain weighs 1,400 g, constituting 5% of the body weight, but it 
receives 15% of the entire cardiac output. Autoregulation is responsible for maintain-
ing constant f low to the cerebral tissue, despite systemic blood pressures that vary 
from a low of 50 to a high of 150 mmHg at normal body temperature (37 °C). This 
window narrows as core body temperature decreases, in such a manner that at 20 °C 
the systemic pressure ranges from 30 to 100 mmHg. Complete loss of autoregulation 
occurs at core body temperatures of less than 12 °C, and cerebral blood flow is then 
directly dependent upon systemic blood pressure and f low.5 Average cerebral f low 
at normal body temperature provides 55 mL of blood per 100 g of brain tissue per 
minute, and oligemia occurs when flow decreases to between 20 and 55 mL/100 g/
min. Frank ischemia occurs when flow decreases to below 20 mL/100 g/min, and neu-
ronal dysfunction results. At flows of less than 10 mL/100 g/min, electrolyte release 
and neuronal death ensue.6 Hypothermia extends ischemic tolerance by reducing the 
brain’s metabolic demands.
Neurologic Injury
Neurologic injury is categorized in accordance with the severity and duration of clini-
cal injury, without consideration of cause or origin. According to Roach,7 type 1 injury 
includes stroke (whether fatal or nonfatal), transient ischemic attack, hypoxic encepha-
lopathy, stupor, or coma. Type 2 includes decreased intellectual function, confusion, 
agitation, disorientation, memory deficit, or seizure (without focal deficit).7 Ergin’s 
classification8 accounts for reversibility: those who sustain permanent injury (stroke 
and coma) are differentiated from those whose condition can possibly be reversed 
(temporary neurologic dysfunction).
Malperfusion or Emboli?
Historically, many reports have implicated cerebral malperfusion as the cause of neuro-
logic injury during aortic arch surgery. For this reason, much emphasis has been placed 
on the type of cerebral perfusion used (that is, antegrade or retrograde). Undoubt-
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edly, warm ischemia leads to neurologic dysfunction, 
but most neurologic injuries (strokes) occur as the result 
of emboli (60% of the time) rather than hypoperfusion, 
which accounts for only 10% of strokes.9,10 Therefore, in 
addition to the type of cerebral perfusion implemented 
during PHCA, many other variables need to be consid-
ered and optimized during aortic arch repair (Table I). 
Each cardiovascular unit’s approach to arch surgery is 
unique. Although each unit’s particular combination 
of cerebral perfusion adjuncts, cannulation approaches, 
monitoring techniques, and anesthetic methods has 
been standardized within the unit, its overall approach 
is unlike that of any other unit. In any attempt to deter-
mine equivalence, this uniqueness renders comparison 
difficult.
Profound Hypothermic Circulatory Arrest
Ever since profound hypothermic circulatory arrest was 
popularized by Griepp and colleagues in 1975,3 it has 
remained the primary approach (or an adjunct) dur-
ing aortic arch repair. Although profound hypothermia 
reduces metabolic demand, its duration of protection 
is limited because demand never reaches nil. At nor-
mal body temperature, the oxygen demand of the brain 
is 2.9 mL/g/min. At 25 °C, the demand drops to 0.9 
mL/g/min, and, at 20 °C, it drops to 0.2 mL/g/min.5 
Animal studies have shown that even at very low sys-
temic temperatures (8 °C), metabolic demand remains 
at 11% of baseline.11
 Recently, Elefteriades and colleagues12 have reported 
respectable results with the use of PHCA alone during 
arch repairs. In a series of 394 patients undergoing as-
cending aortic and aortic arch repair (both elective and 
emergent), the early mortality rate was 6.3% (25/394). 
The stroke rate for ascending and arch repair was 3.1% 
(11/356), when 38 patients with descending and tho-
racoabdominal aortic aneurysms were excluded. As 
expected, patients with PHCA times of greater than 
40 minutes experienced a higher stroke rate (13.1%, or 
8/61). This supports the earlier report of Crawford and 
associates,4 wherein a PHCA time of longer than 40 
minutes was associated with increased risk of stroke. In 
a separate report, Elefteriades’ group also showed that 
the use of PHCA alone could be performed without late 
neurologic sequelae even in patients with demanding 
cognitive professions.12
 The only randomized, controlled trial in human be-
ings that compared PHCA alone with antegrade ce-
rebral perfusion (ACP) revealed no difference in early 
and late neurologic outcomes, despite improved jugular 
venous oxygen saturation when ACP was used. Admit-
tedly, the authors acknowledged that the study was un-
derpowered for clinical outcomes.13
 Because few clinical data counter the use of PHCA 
alone during arch repairs, especially when PHCA time 
takes less than 30 minutes, PHCA alone or in combi-
nation with other perfusion techniques remains accept-
able for transverse arch repairs that take less than 30 
minutes.
Antegrade Cerebral Perfusion
Antegrade cerebral perfusion in combination with 
PHCA was f irst reported by Frist and colleagues14 in 
1986 and later was popularized independently by Ba-
chet15 and Kazui16 and their respective colleagues in the 
early 1990s. The technique used direct cannulation of ei-
ther cold or moderately cold blood in combination with 
PHCA. Subsequent animal data, together with clinical 
experience, led to the increased adoption of ACP.
 Although many experimental animal and patient 
cohort studies have been performed with ACP, only 3 
prospective randomized controlled trials have compared 
ACP with retrograde cerebral perfusion (RCP). Okita 
and associates17 studied a total of 60 patients (30 with 
ACP and 30 with RCP) and found a decreased rate of 
total neurologic deficit in the ACP group (33% vs 13%, 
P <0.05) but found no difference between groups in 
rates of death, stroke, or neurocognitive deficit. Veri-
fication of adequacy of the RCP was not performed in 
this study. In an earlier report, Tanoue and co-authors18 
used transcranial Doppler ultrasonography to verify ce-
rebral blood flow in 32 patients (15 with RCP and 17 
with ACP). This study found improved cerebral blood 
f low in the ACP group. Only 3 patients in the RCP 
group showed evidence of reversal of cerebral blood. 
This low incidence of identif ication of f low reversal 
can be attributed to the technique of RCP used in the 
study: the superior vena cava pressure was only 15 to 
TABLE I. Neurologic Injury Prevention during Arch Repair
Cerebral monitoring (cerebral oximetry, TEE, epiaortic 
ultrasonography, EEG, TCD)
Atheroma avoidance (TEE, epiaortic ultrasonography)
Cross-clamping
Cardiotomy suction regulation
Pump filter modification
Cannulation (location)
Temperature management
pH strategy (alpha and pH quickly)
Perfusion pressure management
Cerebral perfusion technique (PHCA alone, RCP, ACP)
Hematocrit management
Blood conservation
Pharmaco-cerebroprotection
 
ACP = antegrade cerebral perfusion; EEG = electroencepha-
lography; PHCA = profound hypothermic circulatory arrest; 
RCP = retrograde cerebral perfusion; TCD = transcranial 
Doppler ultrasonography; TEE = transesophageal echocar-
diography
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25 mmHg. In addition, the cerebral perfusion time 
was 71 minutes in the ACP group, but only 38 min-
utes in the RCP group (P=0.0047). No difference in 
clinical outcomes was noted; probably, the study was 
not sufficiently powered to show a difference.18 A third 
prospective randomized controlled trial was performed 
by Harrington and colleagues,13 who compared ACP to 
PHCA alone and noted improved jugular venous oxy-
genation but no improvement in early or late clinical 
outcomes.
 Recent studies with antegrade cerebral perfusion have 
reported excellent clinical outcomes, but variations in 
technique make it difficult to determine if ACP alone 
was responsible.19 The limitations, in common with 
those of most such clinical studies, included differ-
ences in cannulation, delivery of perfusate (unilateral 
vs bilateral), amount of perfusate, and temperature of 
perfusate.20 In addition, moderate hypothermia has now 
been adopted, and this varies the technique still more.21 
The use of moderate hypothermia with circulatory ar-
rest has been suggested for the purpose of reducing the 
deleterious effects of profound hypothermia, specifically 
coagulopathy, but the potential for multiorgan dysfunc-
tion, such as spinal cord or renal dysfunction, is worri-
some. Results are preliminary at this point.
Retrograde Cerebral Perfusion
The suggested benefits of RCP include evenly distrib-
uted cooling (70% of the cerebral blood volume resides 
in the venous system), flushing of atheromatous débris, 
and potential for providing nutritive f low. Although 
several animal and clinical studies have reported the 
superiority of ACP to RCP, only 3 prospective ran-
domized controlled trials, albeit with small cohorts, 
have been performed, and they have reported no dif-
ferences in clinical outcomes.17,18,22 Whether outcomes 
would have been different with larger cohorts remains 
unclear, but it must be recognized that the optimal ap-
proach to delivery of either ACP or RCP might not have 
been achieved.
 We adopted the use of Power Mode Transcranial 
Doppler (PM-TCD) and identified reversal of flow in 
the middle cerebral artery, which suggests that flow can 
be supplied to the cerebrum.23 The adequacy of this flow 
in human beings, however, was not studied and remains 
a question. At any rate, we learned that cerebral perfu-
sion could be achieved clinically, provided that the tech-
nique was modified. The standard approach of infusing 
500 cc/min at a jugular pressure of between 15 and 25 
mmHg was not adequate for all patients. Using PM-
TCD, we found that an “opening” pressure and flow 
was required to identify reversal of flow, after which a 
decreased or “dial-down” flow could be performed. The 
“maintenance” flow would then maintain cerebral flow 
at a jugular pressure close to what had been used as the 
standard (that is, 15–25 mmHg).23
 The clinical benefit of RCP has been shown in both 
animal and clinical studies.24,25 In the largest series (more 
than 1,200 cases) reporting use of RCP, the overall rate 
of early death was 9.9%, with a stroke rate of 2.7%. It 
is worth noting that the only independent factor protec-
tive against both stroke and early death was RCP.26
 It is intuitive that ACP may be superior to RCP in 
providing cerebral perfusion, but the clinical proof has 
not been apparent and the reasons for this are unclear. 
Although ACP may provide superior cerebral perfusion, 
it requires manipulation of the head vessels, which in-
creases the risk of emboli. Retrograde cerebral perfusion 
requires no manipulation of head vessels and provides, 
further, the ability to f lush atheromatous débris from 
the cerebral circulation. This is the probable reason that 
the superiority of one approach over another has been 
difficult to demonstrate.
Integrated Cerebral Perfusion
Conklin and colleagues27 first reported the integration 
of both perfusion approaches in order to combine their 
advantages. The small pilot series reported 1 stroke in 
11 patients.
 We performed a prospective cohort study that used 
an integrated cerebral perfusion approach similar to 
Conklin’s, in patients who needed more than 40 min-
utes of PHCA. This study in 56 patients did not reveal 
any significant clinical differences, although trends in 
higher total neurologic deficit, stroke, and death were 
observed in the integrated approach.28 For this reason, 
we continued to use RCP.
Recommendations
The superiority of one perfusion approach over another 
will be very difficult to determine without multicenter 
randomized prospective controlled trials. Furthermore, 
TABLE II. Recommendations for Cerebral Perfusion 
Approach during Aortic Arch Repair
 Circulatory           Cerebral 
 Arrest Time (min) Perfusion Approach
 <30 PHCA alone
  RCP with PHCA
  ACP with PHCA or moderate 
  hypothermia
 30 to 60 RCP with PHCA
  ACP with PHCA or moderate 
  hypothermia
 >60 RCP with PHCA (possible)
  ACP with PHCA
 
ACP = antegrade cerebral perfusion; PHCA = profound 
hypothermic circulatory arrest; RCP = retrograde cerebral 
perfusion
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the complexity of performing arch surgery makes such a 
trial inherently difficult. Controlling all of the variables 
required, including the surgeon-specif ic variables, is 
probably impossible; therefore a clinical difference will 
always be difficult to identify in a definitive manner.
 At any rate, the current clinical evidence suggests that 
any approach, whether PHCA alone, RCP, or ACP can 
be used if cerebral circulatory arrest time remains under 
30 minutes; that the addition of RCP or ACP might 
improve outcomes if circulatory arrest time is longer 
than 30 minutes but shorter than 60 minutes; and that 
ACP and RCP may provide respectable outcomes when 
circulatory arrest time is longer than 60 minutes (Table 
II).
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